Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 14:28:46 +0200Thu, 14 Mar 2024 15:19:00 +0100Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/paxlovidHuman medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/paxlovidThu, 14 Mar 2024 15:19:00 +0100Human medicinePaxlovid : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-5973-aa_en.pdfPaxlovid : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-5973-aa_en.pdfFri, 28 Jan 2022 14:03:00 +0100Human medicine